E EMERRX BIOPHARMA
Live / Applied — Opposition pending (as of 20 Feb 2026)
What this means for you
Not registered yet, but its 08 May 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99176582
- Mark type
- Design + words
- Filed
- 08 May 2025
- Published for opposition
- 25 Nov 2025
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment and prevention of opioid overdose; Pharmaceutical preparations for the treatment of opioid overdose; Pharmaceutical preparations in the nature of intranasal naloxone for the treatment and reversal of opioid overdose; Drug delivery agents in the form of intranasal sprays that facilitate the delivery of pharmaceutical preparations
Owner
- EmerRx Biopharma, LLC, Alameda, CA, US
- EmerRx Biopharma, LLC, Alameda, CA, US
Prosecution history
- 25 Mar 2026 — EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
- 20 Feb 2026 — OPPOSITION INSTITUTED NO. 999999
- 18 Dec 2025 — EXTENSION OF TIME TO OPPOSE RECEIVED
- 03 Dec 2025 — WITHDRAWAL OF ATTORNEY GRANTED
- 03 Dec 2025 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED
- 26 Nov 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 26 Nov 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 26 Nov 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 25 Nov 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 25 Nov 2025 — PUBLISHED FOR OPPOSITION
- 19 Nov 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 23 Oct 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 14 Oct 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 14 Oct 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 14 Oct 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED